Studii clinice pentru Lupus în Tennessee
13 studii pentru Lupus caută participanți în Tennessee.
Orașe în Tennessee
Text oficial al studiului (în engleză)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50001, Jackson
- Sl0044 50693, Murfreesboro
În curs de recrutareFaza 3
Vârste de 16 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
În curs de recrutareFaza 2
Vârste de la 18 la 74 · Toate sexele · Actualizat 1 oct. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
În curs de recrutareFaza 3
Vârste de la 12 la 100 · Toate sexele · Actualizat 1 oct. 2026 · NCT06133972A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Memphis
- Research Site, Memphis
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 25 sept. 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- West Tennessee Research Institute, Jackson
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- West Tennessee Research Institute - Jackson /ID# 284561, Jackson
În curs de recrutareFaza 1
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT07607964A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Murfreesboro Medical Clinic, Murfreesboro
În curs de recrutareStudiu observațional
Vârste de 16 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07175285A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Private Practice - Dr. Ramesh C. Gupta /ID# 275826, Memphis
În curs de recrutareFaza 1
Vârste de la 18 la 75 · Toate sexele · Actualizat 10 aug. 2026 · NCT06977724A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Memphis
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 27 iul. 2026 · NCT07260877A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Regional One Health, Memphis
În curs de recrutareFaza 1
Vârste de la 18 la 70 · Toate sexele · Actualizat 5 iun. 2026 · NCT066133602-HOBA in Systemic Lupus Erythematosus
- Vanderbilt University Medical Center, Nashville
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Femei · Actualizat 22 mai 2026 · NCT07225543A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Regional One Health, Memphis
În curs de recrutareFaza 1
Vârste de la 12 la 70 · Toate sexele · Actualizat 22 mai 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Vanderbilt University Medical Center, Nashville
În curs de recrutareStudiu observațional
Vârste de la 18 la 110 · Toate sexele · Actualizat 15 apr. 2026 · NCT05934149Sursă: ClinicalTrials.gov, date preluate la 4 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.